SurgiQuest Leadership

Kurt Azarbarzin founded SurgiQuest, Inc. in the spring of 2005 and started operations in April 2006. Mr. Azarbarzin is an accomplished, senior medical device executive with a proven track record of leading the development of over 80 new products, resulting in annual sales of over $910 million during his 25-year career with SurgiQuest, U.S. Surgical/Tyco Healthcare (now Covidien), Spine Wave and Respimetrix. Kurt has gained significant and diversified experience in all facets of product design/enhancement, process/manufacturing engineering, team building, finance, vendor relations, regulatory requirements and quality assurance serving the surgical, cardiovascular, interventional, orthopedic and urological markets.

Kurt Azarbarzin founded SurgiQuest, Inc. in the spring of 2005 and started operations in April 2006. Mr. Azarbarzin is an accomplished, senior medical device executive with a proven track record of leading the development of over 80 new products, resulting in annual sales of over $910 million during his 25-year career with SurgiQuest, U.S. Surgical/Tyco Healthcare (now Covidien), Spine Wave and Respimetrix. Kurt has gained significant and diversified experience in all facets of product design/enhancement, process/manufacturing engineering, team building, finance, vendor relations, regulatory requirements and quality assurance serving the surgical, cardiovascular, interventional, orthopedic and urological markets.

Kurt Azarbarzin founded SurgiQuest, Inc. in the spring of 2005 and started operations in April 2006. Mr. Azarbarzin is an accomplished, senior medical device executive with a proven track record of leading the development of over 80 new products, resulting in annual sales of over $910 million during his 25-year career with SurgiQuest, U.S. Surgical/Tyco Healthcare (now Covidien), Spine Wave and Respimetrix. Kurt has gained significant and diversified experience in all facets of product design/enhancement, process/manufacturing engineering, team building, finance, vendor relations, regulatory requirements and quality assurance serving the surgical, cardiovascular, interventional, orthopedic and urological markets.